Members

SPCTR is developing an AI-driven platform for real-time tissue analysis during cancer surgery. With its first product, surgeons will gain insight into the margins of removed tumour tissue within minutes, enabling them to assess during the same operation whether further tissue removal is necessary.

At STT Products, they develop bespoke, innovative technical solutions for the manufacturing industry. Complex projects such as complete production lines and product handling machines are our speciality. We always work with the client to find the best solution. They are passionate about engineering and about designing and building unique machines.

Next-Gen Tracer for Infection Imaging Sabiad’s solution is a major innovation in the field of infection imaging. It uses monoclonal antibodies, making the diagnosis of Staphylococcus Areus related infections in the (orthopedic) implant area not only accurate but also fast and minimally invasive.

• L.J. Zielstraweg 1, 9713 GX Groningen

Sencilia is an early-stage MedTech startup that was spun out of the University of Groningen. We specialize in micro and nanotechnology and are experts in developing bioinspired MEMS sensors. The mission of our company is to improve patient safety using our patent-pending MEMS sensor technology, and our first offering is an IV infusion flow monitoring device. Our smart hardware/software product will improve the safety of IV therapy, thereby enhancing patient outcomes and reducing healthcare costs associated with preventable adverse drug events.

More than thirty years of continuous innovation have established Spark Holland’s reputation as a leading provider of technology for online devices and systems, especially in the field of liquid sample introduction and online SPE.

SteriNoord is the Benelux's largest medical sterilization center, delivering safe, reliable, and high-quality reprocessing of medical instruments with state-of-the-art technology and expert professionals.

Symeres is the leading mid-sized transatlantic Contract Research Organisation (CRO) for your drug discovery and development challenges. Our services cover the entire process, from identifying early-stage hits to the delivery of your early-stage clinical active pharmaceutical ingredient (API). We combine extensive scientific expertise with ingenuity to make significant strides on your behalf.

This invention involves a unique, inventive, and patented tablet formulation that allows STS to be administered orally in an effective and safe manner, enabling chronic treatment with STS. This has been demonstrated in vitro. The VFF plan represents the next step toward achieving proof of concept for STS as a treatment for CVDs through a clinical study in patients with Raynaud's syndrome.